Psoriasis Action Month: Immune-Mediated Dermatologic Conditions and COVID-19 Illness

August marks the beginning of Psoriasis Action Month, an observance organized by the National Psoriasis Foundation which aims to support patients with the common skin condition while promoting awareness and furthering efforts to find a cure for psoriatic disease. While the coronavirus continues to evolve and research efforts attempt to keep up with its changing manifestations, […]

Some Patients Report Swelling After Receiving Facial Filler and COVID Vaccine 

Recent reports of hypersensitivity to injectable dermal fillers containing hyaluronic acid (HA) concurrent with COVID-19 infection or vaccination have been documented by The Journal of Cosmetic Dermatology and the U.S. Food and Drug Administration (FDA). Symptoms, reported by three clinical trial recipients of the Moderna vaccine, were swelling of the facial areas in which each individual received injectable fillers (cheeks and lips). Two patients had gotten dermal filler in the cheeks within the six months prior to vaccination, and the other […]

The Impact of COVID-19 on the Dermatologic Healthcare Community

The COVID-19 pandemic has proven widespread, global effects which span further than just the immense death rates from country to country. As the infection and mortality numbers continue to increase, clinicians worldwide must still evaluate, diagnose, and treat patients for all medical issues whether those issues are related to COVID-19 or not. Along with its […]

Updated COVID-19 Recommendations for Patients with Psoriatic Disease

With the novel coronavirus outbreak continuing to evolve as a public health concern, the need for tailored medical guidance and updated clinical recommendations is emerging across specialties. General guidelines issued by the CDC and WHO, such as social distancing and self-isolation when possible, apply to all individuals. However, the coronavirus may have challenging implications on the […]